ARCHIVES

R01 Payline To Increase From 21st to 22nd Percentile; Barcelona Hospital Wins BMS Cancer Research Grant

This article is from The Cancer Letter archive.

Vol. 28 No. 24 | June 14, 2002

Download PDF Visit The Full Archive

Related Articles

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

December 28, 2012

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

November 25, 2011

Biomarker May Predict Prostate Cancer Metastases

December 27, 2013

News Organizations Protest invitation-Only Press Conferences, Exclusion of Reporters

May 20, 1994

Study Finds Gene Expression Test Predicts Stage I or II Recurrence

August 30, 2013

In Brief: James Downing named CEO of St. Jude

June 27, 2014